Acceptabilité et intérêt de l’auto-injection de gonadotrophines pour la stimulation en vue d’une insémination intra-utérine

Gynecologie Obstetrique Fertilite

Volumn 29, Issue 10, 2001, Pages 662-667

  Zorn, J R ^a   Coffineau, A ^a   Abirached, F ^a   Sari, Y ^b  

^a Hôpital Cochin ^*  (France)

^b Organon   (France)

Author keywords

FSH; Initiation; Intra uterine insemination; Self injection

Indexed keywords

ESTRADIOL; FOLLITROPIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL ARTICLE; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; INFERTILITY THERAPY; INTRAUTERINE INSEMINATION; MALE; MULTIPLE PREGNANCY; OVARY HYPERSTIMULATION; OVULATION; QUESTIONNAIRE; SELF INJECTION; SPERMATOZOON COUNT;

EID: 0035170097     PISSN: 12979589     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-9589(01)00207-7     Document Type: Article

References (7)

1. Subcutaneous gonadotrophin therapy in male patients with hypogonadotropic hypogonadism
2. Human chorionic gonadotrophin self-administrated by the subcutaneous route to induce oocyte maturation in an in vitro fertilization and embryotransfer programme
3. Retrospective analysis of subcutaneous administration of urinary gonadotrophins in in-vitro fertilisation
4. Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotropin
5. Simplification of IVF: Minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction
6. A prospective, randomised study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon®)
7. Subcutaneous versus intramuscular self-administration of highly purified urofollitrophin in superovulation for in vitro fertilisation: A randomised, crossover study of patients's preferences and tolerability